|
|||
|
|
|||
|
 |
Important safety information | Prescribing Information | Glossary | |
 | |||
|
GlossaryBasal insulin: the insulin that provides the body with a steady, low level of insulin throughout the day and night; may be given by intermediate- or long-acting insulin injections or continuous release of faster-acting insulin in a pump Bolus insulin: the faster-acting (either regular or rapid-acting) insulin that provides the boost of insulin needed to stop the rise in blood glucose levels that occurs after meals; may be given as a before-meal injection or a before-meal dose via an insulin pump Velosulin BR Human: (Buffered Regular Human Insulin Injection [rDNA origin]) was initially designed for pump patients to prevent clogging in the pump tubing. Discontinued 11/2003 Cannula: a soft plastic tube Glucose: also known as blood sugar; produced when the digestive system breaks down food; provides fuel for the body Insulin analog: a type of insulin in which the chemical structure of the insulin molecule has been changed in some way Hyperglycemia: abnormally high levels of glucose in the blood Hypoglycemia: abnormally low levels of glucose in the blood Infusion line: a sterile tube used to deliver a medication or other substance into the body Ketoacidosis: a serious condition caused by too little insulin; caused by high levels of glucose and ketones in urine Ketones: waste created when fat cells are burned for energy. In large amounts, ketones alter the blood chemistry and can lead to diabetic ketoacidosis Physiologic: similar to the way the human body works naturally Rapid-acting insulin analog: an insulin that works faster and for a shorter period of time compared with regular human insulin; created by changing the chemical structure of the insulin molecule Regular human insulin: a fast-acting insulin that may be taken before meals; meals may be eaten 30 minutes after insulin injection |
 |
|||||||||||||||||||||||||||||||||||
 | |
|
NovoLog® [insulin aspart (rDNA origin) injection]Indication and Usage: NovoLogŪ is a man-made insulin that is used to control high blood sugar in adults and children with diabetes mellitus. Important Safety Information: NovoLogŪ is a fast-acting insulin. You should eat a meal within 5 to 10 minutes after using NovoLogŪ to avoid low blood sugar. Do not inject NovoLogŪ if you do not plan to eat right after using NovoLogŪ. Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLogŪ. Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin. Do not mix NovoLogŪ with any other insulins when used in a pump or with any insulins other than NPH when used with injections by syringe. Do not take NovoLogŪ if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in NovoLogŪ. If you take too much NovoLogŪ your blood sugar may fall too low. Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLogŪ dose may change if you take other medicines. The most common side effect of insulin therapy, including NovoLogŪ is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information. FlexPen® and NovoLog® are registered trademarks of Novo Nordisk A/S. Disclaimer | Privacy | Contact Us | Novonordisk-us.com
|
 | |
